Illumina, Inc. (NASDAQ:ILMN) rose 16.60% during previous trade. BofA/Merrill issued rating on the stock of Illumina, Inc. (NASDAQ:ILMN) in a research note issued to investors on Jan-10-17, the stock received “Upgrade” rating from Neutral to Buy. Additionally CL King issued their verdict on the stock of the company, on record date of Jan-06-17 the stock was “Upgraded” from Neutral to Buy besides that on Dec-07-16 Illumina, Inc. (NASDAQ:ILMN) was “Reiterated” by Morgan Stanley as Underweight from $115 to $100. Furthermore on Nov-10-16 the stock was “Resumed” by Leerink Partners as Mkt Perform.
Illumina, Inc. (NASDAQ:ILMN) shares ended last trading session at the price of $165.04 whereas a number of traders indicating mean target price will hit $145.83 over the next twelve months, mean value of price target most recently revised on 01/06/17. Illumina, Inc. (NASDAQ:ILMN)’s highest estimates of price target are $180 and low forecast is $100 based on the opinion of 18 analysts. The price target estimates represents a standard deviation of 20.33. However brokerage recommendations suggests an ABR of 2.64 based on calls of 16 experts, where 5 brokers polls the stock a Strong Buy, 1 suggest the stock a Buy, 7 suggest Hold, 0 are rating the stock as Sell while 3 as Strong Sell.
Illumina, Inc. (NASDAQ:ILMN) is expected to release the earnings of its current quarter on 2/7/17. The company is expected to release $0.81 EPS for current quarter according to 21 analysts whereas the company reported $0.81 EPS during same quarter a year ago. For the current quarter the stock has lowest EPS estimates of $0.75 and high estimate of $0.86. For the current year Illumina, Inc. (NASDAQ:ILMN) has set to release EPS of $3.32 as per the sentiments of 22 analysts, however according to 23 analysts, the company expected to release $3.65 EPS for next year.
Illumina, Inc. (NASDAQ:ILMN)’s average revenue estimates for the current quarter are $612.5M according to 18 number of analysts. However its lowest revenue estimates are $607M and highest revenue estimates are $619.1M. A year ago the company’s sales were $591.55M. Its yearly sales growth estimates are 3.50%. For the next quarter the company has anticipated average revenues of $627.81M, according to the sentiments of 12 analysts. For the current year the company has fixed $2.4B revenues, as per the opinion of 20 analysts. For the current year the company has low revenue estimates of $2.39B in contradiction of high revenue estimates of $2.48B. Whereas for the next year revenues are set at $2.65B by 20 analysts.
The stock exchanged hands 6.03M shares versus average trading capacity of 1.38M shares, while its shares’ total market worth is $24.25B along with 146.90M outstanding shares. Illumina, Inc. (NASDAQ:ILMN) shares were trading -11.69% below from the 52-week high price mark of $186.88 and +38.26% above from the 52-week price bottom of $119.37. However the company observed 52 week high price on 10/06/16 and witnessed 52 week low price on 12/07/16. The company’s price sits 24.65% above from its 50-day moving average of $131.26 and 10.34% far from the stock’s 200-day moving average which is $150.75. Illumina, Inc. (NASDAQ:ILMN)’s price to sales ratio for trailing twelve month stands at 10.21, whereas its price to book ratio for most recent quarter sits at 10.81. However the company’s price to cash per share for most recent quarter stands at 15.76. Its price to free cash flow for trailing twelve months is 57.37.